1月30日，力聚热能盘中上涨2.04%，截至09:44，报64.66元/股，成交687.84万元，换手率0.47%，总市 值58.84亿元。 声明：市场有风险，投资需谨慎。本文基于第三方数据库自动发布，不代表新浪财经观点，任何在本文 出现的信息均只作为参考，不构成个人投资建议。如有出入请以实际公告为准。如有疑问，请联系 biz@staff.sina.com.cn。 力聚热能今年以来股价跌1.24%，近5个交易日跌2.55%，近20日跌1.24%，近60日涨17.76%。 责任编辑：小浪快报 资料显示，浙江力聚热能装备股份有限公司位于浙江省湖州市吴兴区埭溪镇上强工业园区茅坞路9号， 成立日期2006年6月27日，上市日期2024年7月31日，公司主营业务涉及热水锅炉与蒸汽锅炉的研发、生 产和销售,产品用于供应采暖和生活用水,以及供应工业生产所需的蒸汽。主营业务收入构成为：工业锅 炉93.56%，维保及合同能源管理6.17%，其他(补充)0.27%。 分红方面，力聚热能A股上市后累计派现2.27亿元。 机构持仓方面，截止2025年9月30日，力聚热能十大流通股东中，泰康品质生活混合A（010874）、泰 康策略优 ...

截至9月30日，咸亨国际股东户数1.23万，较上期减少8.65%；人均流通股32987股，较上期增加9.47%。 2025年1月-9月，咸亨国际实现营业收入26.95亿元，同比增长35.47%；归母净利润1.28亿元，同比增长 32.45%。 1月28日，咸亨国际盘中下跌2.01%，截至09:43，报21.91元/股，成交8082.39万元，换手率0.90%，总市 值89.89亿元。 资金流向方面，主力资金净流出623.19万元，特大单买入107.76万元，占比1.33%，卖出629.69万元，占 比7.79%；大单买入1551.70万元，占比19.20%，卖出1652.95万元，占比20.45%。 咸亨国际今年以来股价涨33.43%，近5个交易日涨17.54%，近20日涨32.23%，近60日涨33.03%。 资料显示，咸亨国际科技股份有限公司位于浙江省杭州市拱墅区星璜巷101号咸亨科技大厦，成立日期 2008年4月11日，上市日期2021年7月20日，公司主营业务涉及经销国内外知名工器具、仪器仪表类 MRO并生产销售自有品牌产品。主营业务收入构成为：工器具类71.80%，仪器仪表类22.21%，技术服 务 ...

合金投资今年以来股价涨14.42%，近5个交易日涨6.04%，近20日涨7.98%，近60日涨24.62%。 资料显示，新疆合金投资股份有限公司位于新疆乌鲁木齐市新华北路165号中天广场14楼，成立日期 1990年3月12日，上市日期1996年11月12日，公司主营业务涉及镍基合金材料的制造和销售。主营业务 收入构成为：合金棒材39.81%，运输服务36.90%，合金线材21.93%，其他1.37%。 合金投资所属申万行业为：有色金属-金属新材料-其他金属新材料。所属概念板块包括：壳资源概念、 小盘成长、小盘、核电等。 1月26日，合金投资盘中上涨2.10%，截至09:59，报8.25元/股，成交7169.06万元，换手率2.28%，总市 值31.77亿元。 资金流向方面，主力资金净流入162.70万元，特大单买入458.61万元，占比6.40%，卖出346.36万元，占 比4.83%；大单买入1070.68万元，占比14.93%，卖出1020.23万元，占比14.23%。 截至9月30日，合金投资股东户数2.55万，较上期增加13.08%；人均流通股15110股，较上期减少 11.56%。2025年1月-9 ...

资金流向方面，主力资金净流入14.63万元，特大单买入101.85万元，占比6.30%，卖出102.36万元，占 比6.33%；大单买入158.93万元，占比9.84%，卖出143.79万元，占比8.90%。 万德斯今年以来股价涨8.20%，近5个交易日涨4.42%，近20日涨5.05%，近60日跌2.29%。 资料显示，南京万德斯环保科技股份有限公司位于江苏省南京市江宁区乾德路57号，成立日期2007年8 月14日，上市日期2020年1月14日，公司主营业务涉及聚焦有机垃圾业务板块、工业废水业务板块,并且 根据自身战略定位与经营现状,坚持技术工艺的精益化与项目的品质化。主营业务收入构成为：环境整 体解决方案63.15%，委托运营36.17%，其他(补充)0.69%。 1月23日，万德斯盘中上涨2.00%，截至14:05，报26.00元/股，成交1615.79万元，换手率0.74%，总市值 22.10亿元。 万德斯所属申万行业为：环保-环境治理-固废治理。所属概念板块包括：超微盘股、小盘均衡、小盘、 固废处理等。 截至9月30日，万德斯股东户数3714.00，较上期减少11.74%；人均流通股22885股，较 ...

Group 1 - The core viewpoint of the news is that Alloy Investment has shown significant stock performance and financial growth in recent months, indicating a positive trend for the company [1][2]. - As of January 23, Alloy Investment's stock price increased by 2.02% to 8.09 CNY per share, with a total market capitalization of 3.116 billion CNY [1]. - The company has experienced a year-to-date stock price increase of 12.21%, with notable gains of 6.03% over the last five trading days, 9.03% over the last 20 days, and 19.50% over the last 60 days [1]. Group 2 - For the period from January to September 2025, Alloy Investment reported a revenue of 230 million CNY, representing a year-on-year growth of 54.61% [2]. - The net profit attributable to shareholders for the same period was 7.258 million CNY, showing a substantial increase of 124.87% compared to the previous year [2]. - The company has a total of 25,500 shareholders as of September 30, which is an increase of 13.08% from the previous period, while the average circulating shares per person decreased by 11.56% to 15,110 shares [2].

1月23日，特力A盘中上涨2.28%，截至10:00，报19.28元/股，成交7057.52万元，换手率0.95%，总市值 83.11亿元。 资金流向方面，主力资金净流出137.46万元，特大单买入212.25万元，占比3.01%，卖出237.07万元，占 比3.36%；大单买入1225.02万元，占比17.36%，卖出1337.67万元，占比18.95%。 特力A今年以来股价涨10.42%，近5个交易日涨6.34%，近20日涨8.50%，近60日涨5.07%。 分红方面，特力AA股上市后累计派现1.24亿元。近三年，累计派现6853.83万元。 机构持仓方面，截止2025年9月30日，特力A十大流通股东中，南方中证房地产ETF发起联接A （004642）位居第三大流通股东，持股244.97万股，相比上期减少5.83万股。黄金股ETF（517520）位 居第四大流通股东，持股226.05万股，相比上期增加101.86万股。香港中央结算有限公司位居第五大流 通股东，持股214.44万股，相比上期增加45.44万股。南方中证1000ETF（512100）位居第六大流通股 东，持股179.17万股，相比上期减少49 ...

Group 1 - The company plans to repurchase shares through a centralized bidding method, with a total amount between 25 million and 50 million yuan, and a maximum repurchase price of 42.00 yuan per share, which is 33.59% higher than the current price of 31.44 yuan [1] - The stock price of the company has increased by 10.16% year-to-date [1] - The company specializes in the research, production, and sales of chemical pharmaceutical raw materials and formulations, with main revenue sources being 54.15% from risperidone orally disintegrating tablets and 45.13% from compound ferrous sulfate folic acid tablets [1] Group 2 - As of September 30, the number of shareholders is 7,863, a decrease of 2.91% from the previous period, while the average circulating shares per person increased by 2.97% to 7,426 shares [2] - For the period from January to September 2025, the company reported operating revenue of 189 million yuan, a year-on-year decrease of 1.89%, and a net profit attributable to shareholders of 33.14 million yuan, down 2.70% year-on-year [2] - The company has distributed a total of 63.34 million yuan in dividends since its A-share listing, with 52.83 million yuan distributed over the past three years [3]

1月22日，渝三峡A盘中上涨2.04%，截至10:48，报8.00元/股，成交6511.08万元，换手率1.90%，总市值 34.69亿元。 资金流向方面，主力资金净流入320.07万元，特大单买入131.80万元，占比2.02%，卖出132.90万元，占 比2.04%；大单买入1333.89万元，占比20.49%，卖出1012.72万元，占比15.55%。 渝三峡A今年以来股价涨9.59%，近5个交易日涨3.63%，近20日涨7.24%，近60日跌4.19%。 资料显示，重庆三峡油漆股份有限公司位于重庆市江津区德感工业园区，成立日期1992年6月22日，上 市日期1994年4月8日，公司主营业务涉及从事油漆涂料的制造、销售以及化工产品贸易。主营业务收入 构成为：涂料97.65%，其他2.35%。 渝三峡A所属申万行业为：基础化工-化学制品-涂料油墨。所属概念板块包括：清洁能源、小盘价值、 成渝城市群、小盘、业绩反转等。 截至9月30日，渝三峡A股东户数5.35万，较上期减少22.91%；人均流通股8108股，较上期增加 29.71%。2025年1月-9月，渝三峡A实现营业收入2.87亿元，同比增长7.07% ...

Core Viewpoint - The stock of Quan Yang Quan has shown significant growth in recent trading sessions, with a year-to-date increase of 20.12% and a notable rise of 12.16% over the last five trading days [1] Group 1: Stock Performance - As of January 22, the stock price of Quan Yang Quan reached 8.30 CNY per share, with a market capitalization of 5.936 billion CNY [1] - The stock has experienced a trading volume of 33.74 million CNY, with a turnover rate of 0.58% [1] - The stock has been on the "Dragon and Tiger List" once this year, with a net buy of 26.83 million CNY on January 19 [1] Group 2: Financial Performance - For the period from January to September 2025, Quan Yang Quan reported a revenue of 1.022 billion CNY, reflecting a year-on-year growth of 13.68% [2] - The net profit attributable to the parent company for the same period was 24.67 million CNY, marking a 15.20% increase compared to the previous year [2] Group 3: Shareholder Information - As of September 30, 2025, the number of shareholders for Quan Yang Quan was 40,000, a decrease of 6.64% from the previous period [2] - The average number of circulating shares per shareholder increased by 7.12% to 17,864 shares [2] - The company has distributed a total of 800 million CNY in dividends since its A-share listing, with no dividends paid in the last three years [3]

Core Viewpoint - Aotai Bio plans to repurchase shares through centralized bidding, with a total amount between 100 million and 200 million yuan, and a maximum repurchase price of 85.00 yuan per share, which is 23.69% higher than the current price of 68.72 yuan [1] Group 1: Company Overview - Aotai Bio, established on April 17, 2009, is located in Hangzhou, Zhejiang Province, and was listed on March 25, 2021 [1] - The company specializes in the research, production, and sales of in vitro diagnostic reagents, with revenue composition as follows: infectious diseases 42.27%, drug and substance abuse 26.74%, others 9.72%, women's health 8.81%, COVID-19 testing 6.60%, tumors 3.77%, myocardium 1.60%, and others 0.49% [1] Group 2: Financial Performance - As of October 31, Aotai Bio had 5,665 shareholders, a decrease of 1.29% from the previous period, with an average of 13,994 circulating shares per person, an increase of 1.31% [2] - For the period from January to September 2025, Aotai Bio achieved operating revenue of 633 million yuan, a year-on-year increase of 2.44%, while net profit attributable to the parent company was 190 million yuan, a decrease of 3.91% [2] Group 3: Shareholder Information - Aotai Bio has distributed a total of 1.28 billion yuan in dividends since its A-share listing, with 955.6 million yuan distributed over the past three years [3] - As of September 30, 2025, the top ten circulating shareholders included Hong Kong Central Clearing Limited as the sixth largest shareholder with 2.1873 million shares, a decrease of 387,400 shares from the previous period, while Guotai Junan Value Advantage Flexible Allocation Mixed A (000362) entered as the ninth largest shareholder with 713,300 shares [3]